The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Aging Neuroscience
(Dec 2020)
The Future of GDNF in Parkinson's Disease
Fredric P. Manfredsson,
Nicole K. Polinski,
Thyagarajan Subramanian,
Nicholas Boulis,
Dustin R. Wakeman,
Dustin R. Wakeman,
Ronald J. Mandel
Affiliations
Fredric P. Manfredsson
Department of Neurobiology, Barrow Neurological Institute, Phoenix, AZ, United States
Nicole K. Polinski
The Michael J. Fox Foundation for Parkinson's Research, New York, NY, United States
Thyagarajan Subramanian
Department of Neurology and Neural and Behavioral Sciences, Penn State University College of Medicine, Hershey, PA, United States
Nicholas Boulis
Department of Neurosurgery, Emory University, Atlanta, GA, United States
Dustin R. Wakeman
Virscio, Inc., New Haven, CT, United States
Dustin R. Wakeman
Department of Psychiatry, Yale School of Medicine, New Haven, CT, United States
Ronald J. Mandel
Department of Neuroscience, University of Florida, Gainesville, FL, United States
DOI
https://doi.org/10.3389/fnagi.2020.593572
Journal volume & issue
Vol. 12
Abstract
Read online
No abstracts available.
Keywords
Parkinson's disease
gene therapy (GT)
neurotrophic factor
neurturin
clinical trial (2.172)
GDNF (glial cell line-derived neurotrophic factor)
WeChat QR code
Close